AngioDynamics, Inc.
ANGO
$9.52
-$0.08-0.83%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 72.00M | 72.85M | 67.49M | 70.98M | 75.18M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 72.00M | 72.85M | 67.49M | 70.98M | 75.18M |
| Cost of Revenue | 33.15M | 32.94M | 30.77M | 29.57M | 39.32M |
| Gross Profit | 38.86M | 39.91M | 36.72M | 41.42M | 35.86M |
| SG&A Expenses | 36.08M | 36.07M | 36.69M | 35.07M | 36.04M |
| Depreciation & Amortization | 2.60M | 2.56M | 2.57M | 2.57M | 3.29M |
| Other Operating Expenses | -- | -- | -- | 5.76M | -- |
| Total Operating Expenses | 78.65M | 77.92M | 76.20M | 79.65M | 86.78M |
| Operating Income | -6.65M | -5.07M | -8.71M | -8.67M | -11.60M |
| Income Before Tax | -4.41M | -10.85M | -12.67M | -14.14M | -199.74M |
| Income Tax Expenses | -2.00K | -110.00K | 133.00K | -692.00K | -12.00M |
| Earnings from Continuing Operations | -4.41M | -10.74M | -12.80M | -13.45M | -187.74M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.41M | -10.74M | -12.80M | -13.45M | -187.74M |
| EBIT | -6.65M | -5.07M | -8.71M | -8.67M | -11.60M |
| EBITDA | -329.00K | 1.79M | -1.93M | -4.25M | -4.08M |
| EPS Basic | -0.11 | -0.26 | -0.31 | -0.33 | -4.67 |
| Normalized Basic EPS | -0.02 | -0.07 | -0.13 | -0.13 | -0.18 |
| EPS Diluted | -0.11 | -0.26 | -0.31 | -0.34 | -4.67 |
| Normalized Diluted EPS | -0.02 | -0.07 | -0.13 | -0.13 | -0.18 |
| Average Basic Shares Outstanding | 40.85M | 40.92M | 40.65M | 40.43M | 40.23M |
| Average Diluted Shares Outstanding | 40.85M | 40.92M | 40.65M | 40.43M | 40.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |